Imprivata Inc (IMPR) 14.85 $IMPR Be on Top of the Latest

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Imprivata Inc (IMPR) 14.85 $IMPR

Be on Top of the Latest Happenings: Complementary Research on Vivint Solar, Manhattan Associates, Paycom Software, Pixelworks, and Imprivata
PR Newswire - Thu Apr 23, 8:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMPR: 14.85 (-0.16), PXLW: 4.91 (-0.08), VSLR: 14.50 (-0.20), MANH: 54.90 (+0.08), PAYC: 32.91 (-0.14)

NYSE stocks posting largest percentage increases
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
OCR: 86.11 (-0.20), ATI: 34.61 (+0.05), GNE: 11.37 (+0.70), KMB: 111.64 (-0.06), KNL: 23.26 (+0.26), OXM: 79.94 (-0.16), VOC: 6.20 (-0.18), PANW: 153.84 (-0.94), IMPR: 14.85 (-0.16), LRE: 8.69 (+0.11), AMBR: 9.02 (-0.08), DMD: 6.55 (-0.13), GLPW: 12.20 (-0.32), PAYC: 32.91 (-0.14)

Imprivata, Inc. (IMPR) in Focus: Stock Jumps 6.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 8:21AM CDT
Imprivata, Inc. (IMPR) was a big mover last session, as the company saw its shares rise over 6% on the day.
BV: 5.75 (-0.04), IMPR: 14.85 (-0.16)

Imprivata Announces First Quarter 2015 Earnings Conference Call
Business Wire - Fri Apr 17, 8:00AM CDT
Imprivata(R) (NYSE: IMPR), the healthcare IT security company, today announced that the company will release the results for its first quarter ended March 31, 2015 after the market closes on Monday, May 4, 2015. Imprivata will hold a conference call for investors on May 4 at 5:00 p.m. ET during which management will review highlights from the company's first quarter, its business outlook and other matters.
IMPR: 14.85 (-0.16)

Imprivata Cortext Helps Community Hospitals and Wellness Centers Achieve 90th Percentile HCAHPS Scores for Responsiveness of Hospital Staff
Business Wire - Tue Apr 14, 8:30AM CDT
(HIMSS15 booth #3848)--Imprivata(R) (NYSE: IMPR), the healthcare IT security company, today announced that Community Hospitals and Wellness Centers (CHWC) has achieved the 90th percentile HCAHPS scores for responsiveness of hospital staff by replacing all pagers with Imprivata Cortext(R), the secure communications platform for healthcare. Imprivata Cortext enables fast, secure communications and care coordination, which increases efficiency and allows CHWC's clinical staff to spend more time with patients. Replacing pagers with Imprivata Cortext has also helped CHWC improve its HCAHPS scores for hospital quietness by 50 percent.
IMPR: 14.85 (-0.16)

Imprivata Cortext Expands Capabilities to Transform Clinical Communication and Drive Patient Engagement
Business Wire - Mon Apr 13, 3:00PM CDT
(HIMSS15 booth #3848)--Imprivata(R) (NYSE: IMPR), the healthcare IT security company, today announced expanded capabilities of Imprivata Cortext(R), the secure communications platform for healthcare, to improve nursing communication and enable patient engagement. Imprivata Cortext offers an enhanced desktop experience as well as efficient provider-to-patient messaging, delivering fast, secure and reliable communications and coordination across the entire care continuum.
IMPR: 14.85 (-0.16)

Panel of Experts Discuss Technology's Role in Fighting the Opiate Abuse Epidemic
Business Wire - Mon Apr 13, 8:30AM CDT
A recent forum sponsored by Imprivata(R) (NYSE: IMPR), the healthcare IT security company, and hosted by the Massachusetts Health Data Consortium focused on two technology-based strategies--Prescription Monitoring Programs (PMPs) and Electronic Prescribing of Controlled Substances (EPCS)--to help address the national opiate abuse epidemic.
IMPR: 14.85 (-0.16)

Imprivata Introduces Breakthrough Proximity-Based Hands-Free Authentication Solution for Healthcare
Business Wire - Mon Apr 13, 8:30AM CDT
HIMSS15 booth #3848--Imprivata(R) (NYSE: IMPR), the healthcare IT security company, continues to advance its leadership in delivering innovative authentication technologies with the introduction of a breakthrough proximity-based hands-free authentication solution for healthcare. The patented technology wirelessly retrieves and verifies a one-time password (OTP) from a user's mobile device without requiring any manual interaction, enabling fast, convenient two-factor authentication that meets DEA requirements for electronic prescribing of controlled substances (EPCS).
IMPR: 14.85 (-0.16)

Imprivata to Showcase New Innovations that Advance Healthcare IT Security at 2015 HIMSS Annual Conference
Business Wire - Mon Apr 06, 3:00PM CDT
Imprivata(R), the healthcare IT security company, will unveil new technologies at the 2015 HIMSS Annual Conference & Exhibition (April 12-15, 2015 in Chicago) that will advance the company's leadership position in delivering innovative authentication products for healthcare. At HIMSS15, Imprivata will also showcase its current portfolio of leading solutions for authentication, access management, secure communications, and secure signing for electronic prescribing of controlled substances (EPCS) in booth #3848. To schedule a meeting or product demonstration with Imprivata, please visit http://www.imprivata.com/himss15.
IMPR: 14.85 (-0.16)

Imprivata Wins Healthcare Informatics Leading Edge Award for Improving Clinical Workflows
Business Wire - Tue Mar 24, 7:30AM CDT
Imprivata(R) (NYSE: IMPR), the healthcare IT security company, today announced that it has won Healthcare Informatics Leading Edge Award for clinical workflow improvement. Imprivata OneSign(R), the company's leading authentication and access management solution, is used by more than 1,200 healthcare organizations globally to deliver fast, secure access to EHRs, patient information, and virtual desktops, saving up to 45 minutes per care provider, per shift.
IMPR: 14.85 (-0.16)

Recent Developments in Computer Software Companies: Special Research on HubSpot, Imperva, Imprivata, IntraLinks, and King Digital
PR Newswire - Tue Mar 24, 6:40AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMPR: 14.85 (-0.16), IL: 10.15 (+0.10), IMPV: 47.78 (-1.12), KING: 16.76 (-0.25), HUBS: 39.06 (-0.59)

Imprivata: High Expectations Should Prop The Share Price Until At Least Q3
Dallas Salazar - at Seeking Alpha - Wed Mar 11, 12:44PM CDT

IMPR: 14.85 (-0.16)

Webster Bank And The Curious Case Of The Dog And The Diamond
Camellia Capital Management - at Seeking Alpha - Tue Mar 10, 2:50PM CDT

IMPR: 14.85 (-0.16), JPM: 62.60 (-0.20), HQY: 25.52 (+0.39), INOV: 26.67 (-0.32), CSLT: 7.99 (+0.07), WBS: 35.96 (-0.13)

Imprivata (IMPR) CEO Omar Hussain on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 8:49PM CST

IMPR: 14.85 (-0.16)

Imprivata beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 3:32PM CST

IMPR: 14.85 (-0.16)

Imprivata Partners with Symantec to Provide Comprehensive Fingerprint Biometric and Token Solution for Electronic Prescribing of Controlled Substances
Business Wire - Tue Feb 17, 7:30AM CST
Imprivata(R) (NYSE:IMPR), the healthcare IT security company, today announced a partnership with Symantec to provide a comprehensive fingerprint biometric and FICAM-certified Credential Service Provider (CSP) solution for electronic prescribing of controlled substances (EPCS). Symantec Norton Secure Login, acting as the CSP, and Symantec Validation and ID Protection Services (VIP) seamlessly integrate with Imprivata Confirm ID(TM) to simplify the process of identity-proofing and credentialing prescribers to comply with DEA requirements for EPCS. This gives prescribers the flexibility to use the two-factor authentication options that best fit their organizational e-prescribing requirements.
IMPR: 14.85 (-0.16), SYMC: 24.67 (+0.03)

Global Biodiesel Industry Report 2015
M2 - Fri Feb 13, 9:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/nzrws8/global_biodiesel) has announced the addition of the "Global Biodiesel Industry Report 2015" report to their offering. The Global Biodiesel Industry Report 2015 is a professional and in-depth study on the current state of the biodiesel industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The biodiesel market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Biodiesel industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on forty-four industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The biodiesel industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: Chapter One Biodiesel Industry Overview Chapter Two Global Biodiesel Market Status Analysis Chapter Three Major Regions Biodiesel Market Status Analysis Chapter Four Major Countries Biodiesel Market Status and Analysis Chapter Five Major Companies Biodiesel Market Status and Analysis Chapter Six Biodiesel Industry Chain and Marketing Channels Analysis Chapter Seven Biodiesel Industry Segment Market Analysis Chapter Eight Biodiesel Industry Development Trend Chapter Nine Biodiesel New Project Investment Feasibility Analysis Chapter Ten Global Biodiesel Industry Research Conclusions Companies Mentioned - Adm - American Energy Producers - Bio-?lwerk Magdeburg - Biopetrol - Blue Sun Biodiesel - Biox Corporation - Cargill - China Biodiesel International Holding - Crimson Renewable Energy - D1 Oils Plc - Deerfield Energy - Delta American Fuel - Ecomotion - Eagle Biodiesel - Felda Iffco - Gushan Bioenergy - Hebei Huihe Bioenergy - Hero Bx - Hebei Zhongtianming Biofuels - Hengshunda Bio-Energy - Imperium Renewables - Ineos Entreprises - Louis Dreyfus Agricultural Industries - Minnesota Soybean Processors - Rev Biodiesel - Rheinische - Vesta Biofuels - Western Dubuque Biodiesel - Western Iowa Energy For more information visit http://www.researchandmarkets.com/research/nz..._biodiesel
IMPR: 14.85 (-0.16)

Imprivata Announces Revised Fourth Quarter and Full Year 2014 Earnings Release Date
Business Wire - Wed Feb 11, 2:57PM CST
Imprivata(R) (NYSE: IMPR), the healthcare IT security company, today announced a revised date for its fourth quarter and the full year ended December 31, 2014 conference call. Imprivata will now hold a conference call for investors on Tuesday, February 24 at 5:00 p.m. ET during which management will review highlights from the company's fourth quarter and year end 2014 results, its business outlook and other matters. The Company expects to issue the earnings release after the market closes on Tuesday, February 24, 2015.
IMPR: 14.85 (-0.16)

Imprivata Announces Fourth Quarter and Full Year 2014 Earnings Conference Call
Business Wire - Tue Feb 10, 7:00AM CST
Imprivata(R) (NYSE: IMPR), the healthcare IT security company, today announced that the company will release the results for its fourth quarter and the full year ended December 31, 2014 after the market closes on Wednesday, February 25, 2015. Imprivata will hold a conference call for investors on February 25 at 5:00 p.m. ET during which management will review highlights from the company's fourth quarter and year end 2014 results, its business outlook and other matters.
IMPR: 14.85 (-0.16)

32 U.S. Senators urge EPA to approve increased biodiesel volumes
PR Newswire - Mon Feb 09, 6:10PM CST
A bipartisan group of 32 U.S. senators, including Washington state's Patty Murray and Maria Cantwell, is calling on the Environmental Protection Agency to move quickly in approving strong biodiesel volumes under the nation's Renewable Fuel Standards.
IMPR: 14.85 (-0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 2

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 5

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 7

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 3

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 2

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading